Riskpilot← Back to searchSign inGet full accessEspesial Medical AB
ABActiveOrg 5590735105Dalrundan 40Hospital activities · NACE 8610Est. 20161 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
4814400.0%
-117% vs 2023
Equity ratio
99.2%
Financial strength
Net profit 2024
SEK -47K
-121% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -48K | -117% |
| Net profit | SEK -47K | -121% |
| Total assets | SEK 445K | -32% |
| Equity | SEK 441K | -28% |
| Employees | 1 | — |
Legal name
Espesial Medical AB
Org number
5590735105
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
23 augusti 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarbemanning inom hälso- och sjukvård, läkarkonsultuppdrag inom hälso- och sjukvård, konsultuppdrag inom medicinsk forskning, föreläsaruppdrag, äga och förvalta fastigheter och värdepapper, samt annan därmed förenlig verksamhet.
Address
Dalrundan 40
Email
d_espes@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 026 | 0 | 170 | 331 | −0 |
| Staff expenses | — | — | −13 | −15 | −15 |
| EBITDA | 366 | −104 | 113 | 285 | −48 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 366 | −104 | 113 | 285 | −48 |
| Net financials | — | −2 | 0 | 1 | 1 |
| Profit before tax | 366 | −106 | 113 | 287 | −47 |
| Tax | −79 | −0 | −2 | −61 | — |
| Net profit | 287 | −106 | 111 | 225 | −47 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 137 | 611 | 590 | 658 | 445 |
| Equity | 937 | 611 | 538 | 613 | 441 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 200 | 0 | 52 | 44 | 4 |
| Total debt | 200 | — | 52 | 44 | 4 |
EBITDA margin
-4814400.0%
This company
15.8%
Market median
-30470986% vs market
20202024
Equity ratio
99.2%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
-10.7%
This company
18.4%
Market median
-158% vs market
20202024
Net profit margin
-4717700.0%
This company
8.1%
Market median
-58243310% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Espesial Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Daniel Elias Espes | Board of Directors | 0 companies |
| Eva Katrin Espes | Deputy Board Member | 0 companies |